Literature DB >> 10199391

HIV Tat represses transcription of the beta 2-microglobulin promoter.

I R Carroll1, J Wang, T K Howcroft, D S Singer.   

Abstract

The MHC class I complex, which binds and presents peptide antigen, is composed of a class I heavy chain and the beta2-microglobulin light chain. HIV-1, which induces a profound immunodeficiency in infected individuals, encodes proteins that cause decreased expression of class I heavy chain. We now report that the HIV Tat protein, which is a potent transactivator of viral transcription, is also a potent repressor of the beta2-microglobulin gene. Repression is mediated through the basal promoter of the beta2-microglobulin gene, which is shown to be predominantly regulated by an initiator element. Tat repression is further augmented by the short viral transcript, TAR, which interacts with Tat. Tat-mediated repression of beta2-microglobulin expression, together with its known repression of class I gene transcription, provides an effective mechanism by which HIV could prevent cell surface expression of the MHC class I complex and avoid immune surveillance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10199391     DOI: 10.1016/s0161-5890(98)00107-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

2.  Nonstructural Protein 4 of Porcine Reproductive and Respiratory Syndrome Virus Modulates Cell Surface Swine Leukocyte Antigen Class I Expression by Downregulating β2-Microglobulin Transcription.

Authors:  Pengfei Qi; Ke Liu; Jianchao Wei; Yuming Li; Beibei Li; Donghua Shao; Zhuanchang Wu; Yuanyuan Shi; Guangzhi Tong; Yafeng Qiu; Zhiyong Ma
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

Review 3.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

Review 4.  Natural killer cells in HIV-1 infection and therapy.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elisa Zaghi; Clara Di Vito; Domenico Mavilio
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

5.  HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation.

Authors:  Parisa Kalantari; Omid F Harandi; Pamela A Hankey; Andrew J Henderson
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

6.  Genome-wide binding map of the HIV-1 Tat protein to the human genome.

Authors:  Céline Marban; Trent Su; Roberto Ferrari; Bing Li; Dimitrios Vatakis; Matteo Pellegrini; Jerome A Zack; Olivier Rohr; Siavash K Kurdistani
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

Review 7.  Tat gets the "green" light on transcription initiation.

Authors:  John Brady; Fatah Kashanchi
Journal:  Retrovirology       Date:  2005-11-09       Impact factor: 4.602

Review 8.  The role of NK cells in HIV-1 protection: autologous, allogeneic or both?

Authors:  Jef Hens; Wim Jennes; Luc Kestens
Journal:  AIDS Res Ther       Date:  2016-03-18       Impact factor: 2.250

9.  HIV-Tat regulates macrophage gene expression in the context of neuroAIDS.

Authors:  Loreto Carvallo; Lillie Lopez; Jorge E Fajardo; Matias Jaureguiberry-Bravo; Andras Fiser; Joan W Berman
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

10.  Impact of the Variable Killer Ig-Like Receptor-Human Leukocyte Antigen Interactions on Natural Killer Cell Cytotoxicity Toward Foreign CD4 T Cells.

Authors:  Jef Hens; Odin Goovaerts; Ann Ceulemans; Wim Jennes; Luc Kestens
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.